Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Want to earn without upfront costs? Discover ways to earn today without any investment and start boosting your income now.
27,120 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A July data center power surge is lifting select U.S.-listed industrials. Here’s a fresh look at the stocks riding th...
MercadoLibre posted a solid Q4 revenue beat alongside an earnings miss, underscoring margin pressure from growth init...
A regional energy shock is unfolding as the Strait of Hormuz stays shut and exporters curtail shipments. The disrupti...
In uncertain times, one reliable approach is to target recession-resistant dividend stocks. This article shines a lig...
NVIDIA forecasts $1 trillion in AI hardware orders through 2027, highlighting the scale of the AI buildout and its im...
Two popular international ETFs, EEM and IXUS, suit different goals. This guide explains how EEM offers focused growth...
Caris Life Sciences blends lab testing with AI-driven insights to tackle oncology challenges. This piece breaks down ...
Two lesser-known mining names outside China are surging as Pentagon demand and Western reshoring reshape the rare ear...
Bitcoin stalls near $77K as AI-focused Worldcoin jumps 25% in a single session, highlighting a split in crypto market...
The S&P 500 pushed higher for a ninth straight session, yet breadth faded as fewer stocks lifted the index. The ‘brea...
Qualia unveils a Core-integrated AI suite designed to speed title and escrow workflows, including three new tools, at...